Methimazole (Tapazole) Cost in Oregon 2026

What Does Methimazole Actually Cost in Oregon?

Generic methimazole runs about $15 per month at Oregon retail pharmacies in 2026 when paid out of pocket, a fraction of the $80 monthly list price attached to Pfizer's branded Tapazole. The gap exists because multiple generic manufacturers now supply the U.S. market, pushing acquisition costs sharply downward. Brand-name Tapazole is rarely dispensed today; most pharmacists substitute the generic automatically unless a prescriber writes "dispense as written."

Methimazole is the first-line oral antithyroid drug endorsed by the American Thyroid Association for Graves disease and other forms of hyperthyroidism. [1] It works by blocking thyroid peroxidase, the enzyme the gland uses to incorporate iodine into thyroid hormone. A landmark 2005 NEJM review by Cooper confirmed that methimazole achieves euthyroid status faster and with fewer adverse effects than propylthiouracil at equivalent doses. [2]

Dose size affects cost. A patient taking 5 mg once daily will typically pay less than one on 30 mg twice daily because the pill count doubles and sometimes triples. Most Oregon pharmacies price a 30-tablet supply of 5 mg tablets at $10 to $18 and a 60-tablet supply of 10 mg tablets at $14 to $22 cash. Calling ahead or using a price-comparison tool before filling matters because prices vary by as much as $8 between chains in the same zip code. [3]

Pfizer manufactures the brand Tapazole in 5 mg and 10 mg tablets. [4] Generic versions from Cadista, Lannett, and other manufacturers carry the same FDA-approved labeling and bioequivalence data. [5]

Oregon Medicaid (Oregon Health Plan) Coverage for Methimazole

Oregon Health Plan (OHP) covers methimazole with a prior authorization requirement in 2026. Patients enrolled in Coordinated Care Organizations (CCOs) under OHP should expect their prescriber to submit a PA documenting the confirmed diagnosis of hyperthyroidism or Graves disease before the claim processes. [6]

The prior authorization form typically asks for TSH and free T4 lab values, the diagnosis code (ICD-10 E05.00 for Graves disease without thyroid storm), and confirmation that the patient is not pregnant or in the first trimester, when propylthiouracil is preferred per endocrine society guidance. [7] Once approved, most OHP enrollees pay $0 to $1 per fill. Denials are uncommon when lab documentation accompanies the request.

Oregon Department of Human Services publishes the current Preferred Drug List (PDL) quarterly. As of the 2025-Q4 update, methimazole (generic) sits on the preferred tier. [8] Prescribers using the OHP's EHR portal can submit PA requests electronically, which cuts median approval time to roughly 2 business days. Patients whose PA is denied have the right to a 15-day expedited appeal under Oregon Administrative Rule 410-141-3895.

How Commercial Insurance Covers Methimazole in Oregon

Most commercial plans sold through Oregon's health insurance marketplace (OHA Exchange) place generic methimazole on Tier 1 or Tier 2, meaning a copay of $0 to $20 per fill after the deductible is met. [9] Plans that use a deductible-first structure may require full cash price until the deductible resets each January, so patients who start methimazole in late autumn sometimes face two months of higher cost before coverage kicks in.

Employer-sponsored plans in Oregon follow similar tier structures. The ACA requires plans to cover drugs prescribed for chronic conditions, and hyperthyroidism qualifies. [10] Patients should request a formulary exception if their plan places Tapazole brand on a non-preferred tier and the prescriber deems the brand necessary. The exception form requires a letter of medical necessity.

Kaiser Permanente Northwest, Providence Health Plan, Moda Health, and PacificSource all operate in Oregon and list generic methimazole on their 2026 formularies at Tier 1. [11] Patients can verify exact copay amounts on each plan's drug cost estimator tool using the GPI code 4250000010 (methimazole 5 mg tablet).

Compounded Methimazole in Oregon: Legality and Cost

Compounded methimazole is legal in Oregon when prepared by a 503A-licensed pharmacy operating under a valid patient-specific prescription from a licensed prescriber. [12] Oregon State Board of Pharmacy licenses and inspects 503A compounding pharmacies; a list of currently licensed facilities is maintained at pharmacy.oregon.gov.

Why would a patient choose compounded methimazole over a commercially manufactured tablet? The main reasons are dose customization (e.g., 2.5 mg tablets not commercially available), alternate dosage forms (transdermal gel for patients with swallowing difficulty), and sometimes cost. Some 503A pharmacies in Oregon supply compounded methimazole oral capsules for $0 to $20 per month depending on the patient's insurance and the pharmacy's pricing structure. Cash pay at compounding pharmacies often runs $15 to $40 monthly for a standard 5 mg dose. [13]

503B outsourcing facilities, which manufacture in bulk without patient-specific prescriptions, may NOT dispense directly to Oregon retail patients unless specific FDA shortage conditions apply, and methimazole is not currently on the FDA drug shortage list. [14] Prescribers should confirm the compounding pharmacy holds an active 503A Oregon license before writing any compounding order.

The FDA's guidance on compounding makes clear that 503A pharmacies must compound based on a valid prescription for an individual patient. [15] Oregon Board of Pharmacy Rule OAR 855-019-0230 mirrors this requirement. Patients who receive compounded methimazole from an unlicensed or out-of-state facility not registered with Oregon may be receiving a drug that has not been tested for potency, sterility, or stability.

Telehealth Prescribing of Methimazole in Oregon

Oregon law permits telehealth prescribing of methimazole without requiring an in-person visit first, provided the prescriber conducts a clinically appropriate evaluation, reviews relevant labs, and documents the encounter. [16] Senate Bill 1554 (2020) and subsequent Oregon Health Authority telehealth rules codify this standard.

A thyroid-focused telehealth visit typically costs $50 to $150 without insurance. The prescriber orders a TSH and free T4 panel (roughly $30 to $80 cash at LabCorp or Quest in Oregon) before writing the first prescription. Follow-up labs at 4 to 6 weeks are standard practice for titration. [17] After TSH normalizes, most clinicians extend the interval to every 3 to 6 months.

Telehealth platforms serving Oregon patients include HealthRX, Teladoc Endocrinology, Sesame Care, and several Oregon-licensed independent practices. Patients should verify that the prescriber holds an active Oregon medical license before the appointment. The Oregon Medical Board's license lookup tool is available at omb.oregon.gov.

The HealthRX Oregon Methimazole Access Framework assigns patients to one of four pathways based on insurance status and dose:

• Pathway 1 (OHP enrolled): Submit PA with TSH and free T4 labs. Expected copay $0 to $1. Approval typically in 2 business days when labs accompany the request.
• Pathway 2 (Commercial insured, Tier 1 plan): Fill at any in-network Oregon pharmacy. Copay $0 to $20. No PA typically required for generic.
• Pathway 3 (Uninsured or high-deductible): Use GoodRx or SingleCare coupon at Costco, Fred Meyer, or Rite Aid Oregon. Expected cash cost $10 to $18 per 30 tablets.
• Pathway 4 (Dose customization needed): Obtain prescription specifying compound from a licensed 503A Oregon pharmacy. Confirm license at pharmacy.oregon.gov before dispensing.

Discount Programs and Savings Cards for Methimazole in Oregon

Several programs reduce methimazole cost for Oregon patients who pay cash or face high cost-sharing.

GoodRx. Free to join. The GoodRx coupon reduces generic methimazole to $10 to $16 at most Oregon chains (Safeway, Fred Meyer, Rite Aid, Walgreens, CVS) in 2026. [18] GoodRx cannot be combined with Medicaid but can be used instead of commercial insurance when the copay would exceed the GoodRx price.

SingleCare. Also free. SingleCare prices for methimazole at Oregon pharmacies range from $9 to $20 depending on dose and location. [19] The card is accepted at over 35 to 000 U.S. pharmacies.

RxAssist / NeedyMeds. Both databases list patient assistance programs (PAPs) for brand Tapazole through Pfizer's patient assistance portal. Pfizer's Pfizer RxPathways program may cover branded Tapazole at no cost for uninsured patients below 400% of the federal poverty level. [20] Applications require a prescriber signature and proof of income.

Costco Pharmacy (Oregon). Costco Pharmacy in Portland, Salem, Hillsboro, and Clackamas regularly prices generic methimazole at $8 to $12 per 30 tablets without a coupon. Membership is not required to use the pharmacy in Oregon. [21]

Mark Cuban Cost Plus Drugs. As of mid-2025, Cost Plus Drugs lists methimazole 5 mg (90 tablets) at approximately $11.40, or about $3.80 per 10 tablets. Oregon prescriptions can be mailed to any Oregon address. [22]

How Pfizer's Tapazole Savings Card Works in Oregon

Pfizer operates a co-pay savings card for insured patients prescribed brand-name Tapazole. The card is available at tapazole.com and can reduce the brand copay to as low as $0 per month for eligible commercially insured patients. [23] Key restrictions apply: the card does not work for patients covered by any federal or state government plan, including Medicare, Medicaid (OHP), TRICARE, or the VA. Oregon OHP enrollees cannot use the Pfizer savings card.

Eligibility requires a valid prescription for brand Tapazole specifically (not generic methimazole), written with "dispense as written" notation. The maximum annual benefit cap was $5,760 as of 2025 program terms. Income limits do not apply to the commercial copay card, but the prescriber must document a reason for brand-name necessity if the insurer requires a formulary exception. [24]

Oregon pharmacists are required by state law to dispense the generic equivalent unless the prescription specifies otherwise or the patient requests the brand. Patients using the Pfizer card should confirm with their pharmacist that the brand is being dispensed and not auto-substituted.

Clinical Context: Why Methimazole Dosing Affects Total Cost

Methimazole dose ranges from 5 mg daily for mild hyperthyroidism to 60 mg daily in divided doses for severe Graves disease or thyroid storm preparation. [25] Higher doses mean more tablets per month and higher pharmacy costs even at generic prices.

The 2016 American Thyroid Association guidelines recommend starting methimazole at 10 to 30 mg daily for most patients with overt hyperthyroidism and titrating based on free T4 measured at 4-week intervals. [26] Patients who achieve remission after 12 to 18 months of therapy may discontinue the drug entirely; the 50% remission rate after 18 months of treatment is the benchmark cited in ATA guidelines. [27]

Two trials are worth knowing in this context. The NEJM 2005 Cooper review (examining data across randomized controlled trials) found that methimazole-treated patients reached euthyroid status in 3 to 8 weeks at doses of 15 to 40 mg daily and sustained lower rates of agranulocytosis (0.1% to 0.5%) compared to propylthiouracil. [2] A 2019 Cochrane review of antithyroid drug trials confirmed that methimazole produces significantly fewer adverse effects than carbimazole-equivalent dosing while achieving comparable thyroid suppression. [28]

Dose titration visits add to the total cost of care. A TSH plus free T4 panel runs $30 to $80 cash at Oregon LabCorp or Quest locations. [29] Patients on OHP pay $0 for labs. Telehealth follow-up visits for titration are typically $50 to $100 per session without insurance.

Agranulocytosis, the most serious adverse effect, occurs in fewer than 1 in 200 patients and usually within the first 90 days. [30] Oregon patients experiencing fever, sore throat, or mouth sores within the first 3 months of therapy should seek a same-day CBC before assuming the symptom is viral.

Methimazole vs. Radioactive Iodine: Cost Comparison in Oregon

Methimazole is not the only treatment for hyperthyroidism. Radioactive iodine (RAI, I-131) and thyroidectomy are definitive alternatives. Cash cost for RAI at an Oregon nuclear medicine facility runs $1,500 to $3,500 for the procedure itself, not counting follow-up hypothyroidism management (typically levothyroxine for life). [31] Thyroidectomy carries OR facility costs of $15,000 to $40,000 before insurance, plus anesthesia and surgeon fees.

Methimazole at $15 per month for 18 months totals $270 in drug costs alone, making it the lowest-cost initial management option for patients with mild to moderate Graves disease who are not pregnant and who prefer to avoid radiation or surgery. [32] The ATA recommends shared decision-making between the patient and endocrinologist when selecting among these three options. [26]

What Oregon Patients Should Tell Their Prescriber

Patients who want to minimize cost should tell their prescriber three things specifically: that they want the generic dispensed (not brand Tapazole), that they may want to use a discount card instead of insurance depending on their deductible status, and that they are open to a telehealth-only follow-up schedule if it reduces visit costs. A prescriber who knows cost is a priority can write the prescription in a pill-splitting-friendly dose (e.g., 10 mg tablets split in half for a 5 mg dose) to reduce the per-unit price by roughly 40%.

Pill splitting methimazole is generally considered acceptable because the tablets are not extended-release and the drug has a relatively wide therapeutic index at maintenance doses. [33] Patients should confirm with their pharmacist that the specific tablet formulation is scored before attempting to split.

Oregon law does not restrict a prescriber from writing a methimazole prescription after a telehealth visit, from specifying a compounding pharmacy, or from writing for a 90-day supply at a time. A 90-day supply at cash price runs approximately $40 to $50 at most Oregon pharmacies, compared to $45 to $60 for three separate 30-day fills, making the 90-day supply the lower-cost option when the patient's dose is stable.